NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025

A Contract Award Notice
by NHS ENGLAND

Source
Find a Tender
Type
Framework (Goods)
Duration
not specified
Value
£1
Sector
HEALTH
Published
24 Jul 2025
Delivery
not specified
Deadline
n/a

Related Terms

Location

United Kingdom: Please refer to Document 3, Schedule 8 in the ITO Documents for the list of purchasing points

Geochart for 1 buyers and 29 suppliers

1 buyer

28 suppliers

Description

NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025CM/PHR/24/5718/01 - NHS Framework Agreement for Branded Medicines – Tranche A for London and South of England. Period of Framework Agreement: 01 September 2025 to 31 August 2027CM/PHR/24/5718/02 - NHS Framework Agreement for Branded Medicines – Adult Influenza (National). Period of Framework Agreement: 01 September 2025 to 31 August 2026

Lot Division

1 CM/PHR/24/5718/01 - Tranche A for London and South of England

Please check this box if you have offered against Lot 1 of this Project. Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents.
2 CM/PHR/24/5718/02 - National Adult Influenza

Please check this box if you have offered against Lot 2 of this Project. Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents.

Award Detail

1 Roche Products (Welwyn Garden City)
  • Reference: 042580-2025-1
  • Value: £1
2 Amgen (Cambridge)
  • Reference: 042580-2025-2
  • Value: £1
3 Biogen (Maidenhead)
  • Reference: 042580-2025-3
  • Value: £1
4 Teva (Castleford)
  • Reference: 042580-2025-4
  • Value: £1
5 Drreddys Laboratories (Cambridge)
  • Reference: 042580-2025-5
  • Value: £1
6 Orifarm (Brentwood)
  • Reference: 042580-2025-6
  • Value: £1
7 Pfizer (Kent)
  • Reference: 042580-2025-7
  • Value: £1
8 Vifor Pharma (London)
  • Reference: 042580-2025-8
  • Value: £1
9 Accord (Barnstable)
  • Reference: 042580-2025-9
  • Value: £1
10 Sandoz (Bracknell)
  • Reference: 042580-2025-10
  • Value: £1
11 Eli Lilly (Basingstoke)
  • Reference: 042580-2025-11
  • Value: £1
12 Chugai Pharma (London)
  • Reference: 042580-2025-12
  • Value: £1
13 Mylan (Hatfield)
  • Reference: 042580-2025-13
  • Value: £1
14 Aventis Pharma (Reading)
  • Reference: 042580-2025-14
  • Value: £1
15 Manx Healthcare (Warwick)
  • Reference: 042580-2025-15
  • Value: £1
16 Janssen Cilag (High Wycombe)
  • Reference: 042580-2025-16
  • Value: £1
17 Novo Nordisk (Gatwick)
  • Reference: 042580-2025-17
  • Value: £1
18 Sun Pharma (Uxbridge)
  • Reference: 042580-2025-18
  • Value: £1
19 Merck Serono (Feltham)
  • Reference: 042580-2025-19
  • Value: £1
20 Bayer (Reading)
  • Reference: 042580-2025-20
  • Value: £1
21 Napp Pharmaceuticals (Cambridge)
  • Reference: 042580-2025-21
  • Value: £1
22 Astrazeneca (London)
  • Reference: 042580-2025-22
  • Value: £1
23 CST Pharma (Walsall)
  • Reference: 042580-2025-23
  • Value: £1
24 Pharmacosmos (Reading)
  • Reference: 042580-2025-24
  • Value: £1
25 Thornton & Ross (Linthwaite)
  • Reference: 042580-2025-25
  • Value: £1
26 Glaxosmithkline (London)
  • Reference: 042580-2025-26
  • Value: £1
27 Gedeon Richter (London)
  • Reference: 042580-2025-27
  • Value: £1
28 Seqirus (Maidenhead)
  • Reference: 042580-2025-28
  • Value: £1
29 Aventis Pharma (Reading)
  • Reference: 042580-2025-29
  • Value: £1

Award Criteria

price _

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Options are available.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

  • ocds-h6vhtk-04dd23
  • FTS 042580-2025

Domains